By expenditures
| Name | Title | Type |
|---|---|---|
| Mark Kennedy | Chief Financial Officer | Auditee |
| Thure Ross | Signing Director | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 354747 | 2024 | 2025-04-28 | Cliftonlarsonallen LLP | $15.03M |
| 304811 | 2023 | 2024-04-28 | Cliftonlarsonallen LLP | $14.87M |
| 265967 | 2022 | 2023-06-28 | Cliftonlarsonallen LLP | $13.05M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 354747 | 2024 | 2025-04-28 | 1132458 | 2024-002 | Significant Deficiency | - | E |
| 354747 | 2024 | 2025-04-28 | 1132457 | 2024-001 | Significant Deficiency | Yes | G |
| 354747 | 2024 | 2025-04-28 | 556016 | 2024-002 | Significant Deficiency | - | E |
| 354747 | 2024 | 2025-04-28 | 556015 | 2024-001 | Significant Deficiency | Yes | G |
| 304811 | 2023 | 2024-04-28 | 971387 | 2023-002 | Significant Deficiency | - | A |
| 304811 | 2023 | 2024-04-28 | 971386 | 2023-001 | Significant Deficiency | - | G |
| 304811 | 2023 | 2024-04-28 | 394945 | 2023-002 | Significant Deficiency | - | A |
| 304811 | 2023 | 2024-04-28 | 394944 | 2023-001 | Significant Deficiency | - | G |
| 265967 | 2022 | 2023-06-28 | 855549 | 2022-002 | Significant Deficiency | - | N |
| 265967 | 2022 | 2023-06-28 | 855548 | 2022-001 | Significant Deficiency | - | E |
| 265967 | 2022 | 2023-06-28 | 279107 | 2022-002 | Significant Deficiency | - | N |
| 265967 | 2022 | 2023-06-28 | 279106 | 2022-001 | Significant Deficiency | - | E |